A Study of the Cellular and Molecular Mediators of the Adjuvant Action of a Nontoxic Monophosphoryl Lipid A

Publisher Website
Google Scholar
Abstract
With the current resurgence of efforts to improve and expand human vaccines, attention is again being focused on the development of safe and effective adjuvants (17). In particular, the utilization of synthetic antigenic determinants or ligands of low molecular weight, which are inherently weak antigenically, necessitates the use of adjuvant carriers for optimum efficiency.